1991
Vertex was founded in 1989. The Company went public in 1991.
Who founded Vertex Pharmaceuticals?
Joshua Boger
Vertex Pharmaceuticals/Founders
Vertex Pharmaceuticals (NASDAQ:VRTX) is a rare biotech success story. Started in 1989 by chemist Joshua Boger, the company was fueled for many years by three key ingredients: a unique approach to drug discovery, the tenacious dedication of a small group of scientists, and an ambitious long-term vision.
Can you invest in an IPO?
An initial public offering, or IPO, is when a private company first takes its stock shares public. IPO investing can be risky, as the company’s shares have yet to perform on the open market. If you qualify for IPO investing, you can typically do so through your brokerage.
Is VRTX stock a buy?
Out of 17 analysts, 7 (41.18%) are recommending VRTX as a Strong Buy, 5 (29.41%) are recommending VRTX as a Buy, 4 (23.53%) are recommending VRTX as a Hold, 1 (5.88%) are recommending VRTX as a Sell, and 0 (0%) are recommending VRTX as a Strong Sell. What is VRTX’s earnings growth forecast for 2021-2023?
Who is the CEO of Vertex Pharmaceuticals?
Reshma Kewalramani (Apr 1, 2020–)
Vertex Pharmaceuticals/CEO
Reshma Kewalramani Appointed as New Chief Executive Officer. BOSTON –(BUSINESS WIRE)–Jul. 25, 2019– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its Board of Directors has approved the planned transition of Chairman, President and Chief Executive Officer Jeffrey Leiden , M.D., Ph.
How many employees does Vertex Pharmaceuticals have?
3,000
Vertex Pharmaceuticals/Number of employees
Who are the founders of vertex pharmaceutical company?
It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England . Vertex was founded in 1989 by Joshua Boger and Kevin J. Kinsella.
Where is Vertex Pharmaceuticals located in South Boston?
Located on the South Boston waterfront, it marked the first time in the company’s history that all of the roughly 1,200 Vertex employees in the Greater Boston area worked together.
When did Vertex Pharmaceuticals buy out Semma Therapeutics?
In September 2019 the company announced it would acquire Semma Therapeutics for $950 million in cash. Semma Therapeutics created a “small, implantable device that holds millions of replacement beta cells, letting glucose and insulin through but keeping immune cells out.”
When did Vertex Pharmaceuticals acquire Exonics Therapeutics?
In June of the same year, Vertex announced it would acquire Exonics Therapeutics for up to $1 billion and collaborate with CRISPR Therapeutics, boosting its development of treatments for Duchenne muscular dystrophy and Myotonic Dystrophy Type 1. In September 2019 the company announced it would acquire Semma Therapeutics for $950 million in cash.
